Cite
Enasidenib for the treatment of acute myeloid leukemia.
MLA
Dugan, James, and Daniel Pollyea. “Enasidenib for the Treatment of Acute Myeloid Leukemia.” Expert Review of Clinical Pharmacology, vol. 11, no. 8, Aug. 2018, pp. 755–60. EBSCOhost, https://doi.org/10.1080/17512433.2018.1477585.
APA
Dugan, J., & Pollyea, D. (2018). Enasidenib for the treatment of acute myeloid leukemia. Expert Review of Clinical Pharmacology, 11(8), 755–760. https://doi.org/10.1080/17512433.2018.1477585
Chicago
Dugan, James, and Daniel Pollyea. 2018. “Enasidenib for the Treatment of Acute Myeloid Leukemia.” Expert Review of Clinical Pharmacology 11 (8): 755–60. doi:10.1080/17512433.2018.1477585.